Two tales of innovation from CVS and Pfizer
Good afternoon, readers. Innovation takes many forms. One form may be, say, transforming the way…
Pfizer
Pfizer’s high-tech plan to track every dose of its experimental COVID vaccine
COVID vaccine development is complicated, especially in the truncated timeline that the moment calls for….
Pfizer could seek emergency approval for Covid vaccine, but not before US elections
The Pfizer logo on the lab coat of an employee at the company’s research and…
Pfizer’s Albert Bourla: Vaccine efforts are improving Big Pharma’s reputation
This is the web version of CEO Daily. To get it delivered to your inbox, sign…
The rollercoaster of COVID-19 vaccines
Good afternoon, readers. We’ve had a few turbulent developments in the coronavirus vaccine development race….
COVID-19 vaccine still on track for 2020 despite trial pause, AstraZeneca CEO says
© 2020 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance…
Pfizer’s CEO is still hopeful for COVID vaccine progress by October—and says a sense of purpose is fueling him
Pfizer CEO Albert Bourla on Wednesday reiterated his optimistic view that the company’s experimental coronavirus…
Trump wants a COVID-19 vaccine by Election Day. But will one be ready?
There are growing signs that the Trump administration is preparing to license a COVID-19 vaccine…
Salesforce, Amgen, and Honeywell Int’l will join Dow Jones Industrial Average
© 2020 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance…
Scientists to Wall Street: You don’t really understand how COVID vaccine tests work
Our mission to help you navigate the new normal is fueled by subscribers. To enjoy…